Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
- PMID: 30658994
- PMCID: PMC6509007
- DOI: 10.1136/gutjnl-2018-317706
Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
Abstract
Objective: Pancreatic ductal adenocarcinoma (PDA) has among the highest stromal fractions of any cancer and this has complicated attempts at expression-based molecular classification. The goal of this work is to profile purified samples of human PDA epithelium and stroma and examine their respective contributions to gene expression in bulk PDA samples.
Design: We used laser capture microdissection (LCM) and RNA sequencing to profile the expression of 60 matched pairs of human PDA malignant epithelium and stroma samples. We then used these data to train a computational model that allowed us to infer tissue composition and generate virtual compartment-specific expression profiles from bulk gene expression cohorts.
Results: Our analysis found significant variation in the tissue composition of pancreatic tumours from different public cohorts. Computational removal of stromal gene expression resulted in the reclassification of some tumours, reconciling functional differences between different cohorts. Furthermore, we established a novel classification signature from a total of 110 purified human PDA stroma samples, finding two groups that differ in the extracellular matrix-associated and immune-associated processes. Lastly, a systematic evaluation of cross-compartment subtypes spanning four patient cohorts indicated partial dependence between epithelial and stromal molecular subtypes.
Conclusion: Our findings add clarity to the nature and number of molecular subtypes in PDA, expand our understanding of global transcriptional programmes in the stroma and harmonise the results of molecular subtyping efforts across independent cohorts.
Keywords: pancreatic cancer.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: AC is a founder and shareholder of DarwinHealth Inc. and a member of the Tempus Inc. SAB and shareholder. Columbia University is a shareholder of DarwinHealth Inc. KPO is a member of the SAB for Elstar Therapeutics.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6509007/bin/nihms-1019170-f0001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6509007/bin/nihms-1019170-f0002.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6509007/bin/nihms-1019170-f0003.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6509007/bin/nihms-1019170-f0004.gif)
Similar articles
-
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.Clin Cancer Res. 2021 Apr 15;27(8):2314-2325. doi: 10.1158/1078-0432.CCR-20-1039. Epub 2021 Feb 5. Clin Cancer Res. 2021. PMID: 33547202 Free PMC article.
-
Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.Gut. 2019 Mar;68(3):499-511. doi: 10.1136/gutjnl-2017-314353. Epub 2018 Feb 10. Gut. 2019. PMID: 29440233 Free PMC article.
-
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.Gastroenterology. 2018 Dec;155(6):1999-2013.e3. doi: 10.1053/j.gastro.2018.08.033. Epub 2018 Aug 27. Gastroenterology. 2018. PMID: 30165049
-
Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.Am J Physiol Cell Physiol. 2020 Aug 1;319(2):C233-C243. doi: 10.1152/ajpcell.00079.2020. Epub 2020 May 20. Am J Physiol Cell Physiol. 2020. PMID: 32432930 Free PMC article. Review.
-
Tumor-stroma interactions in pancreatic ductal adenocarcinoma.Mol Cancer Ther. 2007 Apr;6(4):1186-97. doi: 10.1158/1535-7163.MCT-06-0686. Epub 2007 Apr 3. Mol Cancer Ther. 2007. PMID: 17406031 Review.
Cited by
-
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.Science. 2024 Jun 7;384(6700):eadk0775. doi: 10.1126/science.adk0775. Epub 2024 Jun 7. Science. 2024. PMID: 38843331 Free PMC article.
-
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC.Front Immunol. 2024 May 16;15:1341079. doi: 10.3389/fimmu.2024.1341079. eCollection 2024. Front Immunol. 2024. PMID: 38817612 Free PMC article. Review.
-
Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex.Int J Mol Sci. 2024 May 7;25(10):5069. doi: 10.3390/ijms25105069. Int J Mol Sci. 2024. PMID: 38791111 Free PMC article. Review.
-
Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO.Cell Rep Methods. 2024 May 20;4(5):100760. doi: 10.1016/j.crmeth.2024.100760. Epub 2024 Apr 26. Cell Rep Methods. 2024. PMID: 38677284 Free PMC article.
-
Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions.Commun Biol. 2024 Apr 9;7(1):430. doi: 10.1038/s42003-024-06087-8. Commun Biol. 2024. PMID: 38594506 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67:7–30. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical